Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Sponsor: Hoffmann-La Roche
Summary
A Prospective, Multicenter, Non-Interventional Study of Primary Data Collection, Designed to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcomes in Patients with Breast Cancer in Latin America.
Official title: A STUDY TO OBSERVE PATIENTS CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER IN LATIN AMERICA
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2907
Start Date
2020-02-21
Completion Date
2026-06-30
Last Updated
2026-03-24
Healthy Volunteers
Not specified
Conditions
Interventions
Bevacizumab
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Trastuzumab
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Ado-trastuzumab emtamsine
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Pertuzumab
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Atezolizumab
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Capecitabine
Dosing and treatment duration of any studied medicinal products collected are at the discretion of the physician in accordance with local clinical practice and local labeling.
Locations (30)
Instituto Alexander Fleming
Buenos Aires, Argentina
Instituto Oncologico De Cordoba
Córdoba, Argentina
Hospital Privado Centro Medico de Cordoba
Córdoba, Argentina
Hospital de Morón
Morón, Argentina
Instituto de Oncología de Rosario
Rosario, Argentina
Sanatorio de la Mujer
Rosario, Argentina
Crio - Centro Regional Integrado de Oncologia
Fortaleza, Ceará, Brazil
Hospital do Câncer de Londrina
Londrina, Paraná, Brazil
Hospital Jardim Amália
Volta Redonda, Rio de Janeiro, Brazil
Inst. de Vita
Caxias do Sul, Rio Grande do Sul, Brazil
Centro de Pesquisa em Oncologia
Porto Alegre, Rio Grande do Sul, Brazil
Instituto Nacional de Cancer - INCa
Rio de Janeiro, Brazil
Instituto Brasileiro De Controle Do Câncer - IBCC
São Paulo, Brazil
Clinica Las Condes
Santiago, Chile
Instituto Nacional del Cancer
Santiago, Chile
Hospital Dr. Hernan Henriquez Aravena
Temuco, Chile
Organización Clínica Bonnadona Prevenir S.A.S
Barranquilla, Colombia
Inst. Nacional de Cancerologia
Bogotá, Colombia
Centro Medico Imbanaco
Cali, Colombia
Fundacion Cardiovascular de Colombia - Instituto del Corazón
Floridablanca, Colombia
Hospital Hermanos Ameijeiras
La Habana, Cuba
Instituto de Oncologia Dr. Heriberto Pieter
Santo Domingo, Dominican Republic
Grupo Angeles
Guatemala City, Guatemala
Instituto Nacional de Cancerologia
Mexico City, Mexico CITY (federal District), Mexico
Hospital Zambrano Hellion TecSalud
Monterrey, Nuevo León, Mexico
Centro Oncologico Estatal ISSEMYM
Toluca, Mexico
Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
Clinica Internacional, Sede San Borja
Lima, Peru
Aliada Centro Oncologico
Lima, Peru
Sanatorio CASMU
Montevideo, Uruguay